SETRONOMET 8 MG (?ONDANSETRON ) 4 ORAL DISINTEGRATING?TABLETS

Indication:

Adults:

Ondansetron is indicated in adults for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy.

Ondansetron is indicated for the prevention of post-operative nausea and vomiting (PONV).

Paediatric Population:

Ondansetron is indicated in children aged ?6 months for the management of chemotherapy-induced nausea and vomiting (CINV).

No studies have been conducted on the use of orally administered ondansetron in the prevention and treatment of PONV in children aged ?1 month, administration by IV injection is recommended for this purpose.